Vireo Advisors, LLC

View Original

Vireo Publishes "Characterization of a Human In Vitro Intestinal Model for the Hazard Assessment of Nanomaterials Used in Cancer Immunotherapy"

Vireo, and our co-authors at Baylor University, have published a study advancing the use of alternative testing strategies for nanomaterial safety assessments.

The study characterizes and demonstrates the use of an in vitro, cell-based intestinal model for nanomaterial hazard assessment. This work, and the work of others in the field, are important for developing the next generation of safety tests that reduce the need for animal testing, while ensuring safety.